BioIVT ADMET Solutions
BioIVT offers a comprehensive range of ADMET products designed to support drug discovery and development. From in vitro ADME assays to toxicology testing solutions, our high-quality biological materials and services enable researchers to evaluate absorption, distribution, metabolism, excretion, and toxicity with accuracy and efficiency.
Diverse Range of Products
Stock in Mumbai
Quality
BioIVT is the worldwide leader of biological ADMET-products to life sciences and pharmaceutical companies.
As the leading provider of human and animal hepatocyte products, BioIVT offers high-quality cells with the most characterization and the largest lot sizes in the industry.
BioIVT Cells and Fractions have:
- Large lot sizes available
- Extensive inventory (in Mumbai and in the US)
- High viability and consistency
- Proprietary technologies for higher quality products
- Specialized test systems
- Supply chain infrastructure with Krishgen and BioIVT working together to ensure cold chain maintanence
Tissue Sub-Cellular Fractions
BioIVT produces subcellular fractions through the process of subcellular fractionation, which is the separation of cellular components. The initial step starts with the homogenization of tissue in an isotonic buffer to aid in the separation of the cellular components.
Through differential centrifugation, BioIVT can isolate purified organelle fractions including:
Used in western blotting, protein binding, enzyme assays and matrix controls to determine if enzyme activity is important for your study.
Learn More.
Microsomes are valuable tools in drug discovery for studying the metabolism of your compounds.
Learn More.
A diverse range of products derived from human liver, lung, kidney, intestine, and skin tissues.
Learn More.
Used in drug development as predictive test systems to evaluate specific drug-metabolizing enzymes that are highly expressed in certain cellular compartments / organelles.
Learn More.
Preparations from liver cells are used in drug development as predictive test systems to evaluate specific drug-metabolizing enzymes that are enriched in certain cellular compartments / organelles.
Learn More.
BioIVT’s standard products feature fully-characterized subcellular fractions from the following toxicologically-relevant species:
Human
Rat/Mouse
Rabbit
Monkey
Mini Pig
Hamster
Guinea-Pig
Dog
Non-Traditional Sub-Cellular Fractions
BioIVT offers non-traditional sub-cellular fractions to support advanced drug metabolism and pharmacokinetic (DMPK) studies. These specialized fractions, from various species, enable researchers to investigate enzyme activity, metabolic stability, and reaction phenotyping with greater flexibility and precision.
Used in western blotting, protein binding, enzyme assays and matrix controls to determine if enzyme activity is important for your study.
Learn more
Microsomes are valuable tools in drug discovery for studying the metabolism of your compound
Learn more
Used in drug development as predictive test systems to evaluate specific drug-metabolizing enzymes that are highly expressed in certain cellular compartments / organelles.
Learn more
Cryopreserved Hepatocytes
Purified frozen liver cells that can be thawed and cultured in a lab. Hepatocytes are the main structural and functional parenchymal cells of the liver.
They make up approx. 80% of the liver, but only 60% of the total liver cells.
Hepatocytes express high levels of transporters and drug metabolizing enzymes (DMEs).
Select the Right Hepatocytes for Your Study
Which in vitro test system best suits my needs?
We offer a wide variety of hepatocyte test systems. We can provide immortalized or primary cells, fresh or cryopreserved, animal or human hepatocytes in the format of your choice. We have individual donor and pooled donors, suspension and plateable cells, and can even plate the hepatocytes for you.
- Human Cryoplateable
- Human Cryosuspension
- Fresh Hepatocytes
- Animal Cryoplateable
- Animal Cryosuspension
- Immortalized Hepatocytes
Choose quality human cryoplateable hepatocytes from BioIVT.
For short-term assays, individual, LIVERPOOL® and Cryostax® human cryosuspension hepatocytes are available.
Freshly isolated hepatocytes are offered from human, rat, dog, monkey and mouse.
For long-term assays, check out the extensive offering of animal cryoplateable hepatocytes.
For short-term in vitro studies, view our extensive animal cryosuspension inventory of preclinical species.
Hepatocytes from the immortalized Fa2N-4 cell line maintain near-normal morphology in culture, suitable for induction screening and lysosomal trapping assays.
BioIVT offers an extensive catalog of recombinant CYPs and purified enzymes, including all the CYPs typically investigated in drug discovery programs.
A comprehensive range of human CYPs co-expressed with human NADPH CYP-reductase with or without human cytochrome b5. The CYPs are available with high or low levels of reductase relative to the CYP, allowing you to choose products that fit your assay.
High Reductase Bactosomes exhibit higher activity but the time for which the reaction is linear is shorter;
Low Reductase Bactosomes have a lower activity but the reaction is linear for longer.
BioIVT also has introduced ranges of animal equivalents for use in the development of veterinary medicines. These include:
Recombinant CYP BACTOSOMES®: Versatile Formats for Many ADME Applications
Recombinant cytochrome P450 (rCYP) enzymes are commonly used in ADME-Tox studies as in vitro tools, mostly for reaction phenotyping, enzyme inhibition screening, clearance and metabolite ID.
Non-CYP Recombinant Enzymes:
BioIVT provides non-CYP recombinant enzymes for reliable in vitro studies of drug metabolism and biotransformation. These high-quality enzymes support research on phase I and phase II metabolic pathways, enabling precise evaluation of compound stability, metabolite profiling, and potential drug-drug interactions.
Featured Products
Cell Selection, Handling & Media Tips to Get the Best Results from Your Hepatocyte Assays
Stock Availability in the Mumbai Warehouse
This stock may have discrepancies as it is not updated in real time. Please get in touch with our team before placing your final order.
CYP533 - (±)-4-hydroxymephenytoin
Pack Size | Batch No. | Stock | COA |
5 mg | 533001 | 3 | NA |
CAN00PLK2PNN-50 - Beagle Plasma K2EDTA Pooled Gender
Pack Size | Batch No. | Stock | COA |
50 ml | BGL122658 | 2 | NA |
50 ml | BGL122659 | 2 | NA |
CYP306 - Canine CYP3A26LR
Pack Size | Batch No. | Stock | COA |
1 nmol | DC3A26LR001 | 1 | NA |
P2000.H15B - Cryopreserved male Cynomolgus monkey hepatocytes
Pack Size | Batch No. | Stock | COA |
1mL | 1510040 | 2 | NA |
1mL | 1410284 | 1 | NA |
AMY 6.0 million cells | 1510189 | 5 | NA |
HP1000.HP - CryostaX Cryopreserved Individual Male Human Hepatocytes – Suspension
Pack Size | Batch No. | Stock | COA |
AMY 5 million cells | H1424 | 30 | HP1000.HP H1424 |
5 million cells | 2410059 | 101 | NA |
5 million cells | 2310140 | 65 | NA |
DPCH1000 - CryostaX Single Freeze Pooled Cryopreserved Beagle Dog Hepatocytes, Male
Pack Size | Batch No. | Stock | COA |
AMY 5 million cells | 2210339 | 36 | DPCH1000 2210339 |
AMY 5 million cells | 2210338 | 39 | DPCH1000 2210338 |
MPCH1000 - CryostaX Single Freeze Pooled Cryopreserved CD1 Mouse Hepatocytes
Pack Size | Batch No. | Stock | COA |
AMY 2 million cells | 2410057 | 41 | MPCH1000 2410057 |
AMY 2 million cells | 2410056 | 32 | MPCH1000 2410056 |
AMY 2 million cells | 2410041 | 13 | MPCH1000 2410041 |
AMY 2 million cells | 2410042 | 38 | NA |
MPCH1000+ - CryostaX Single Freeze Pooled Plateable Cryopreserved CD1 Mouse Hepatocytes
Pack Size | Batch No. | Stock | COA |
AMY 2 million cells | 1810191 | 2 | NA |
HPCH10 - CryostaX, Single Freeze Pooled Cryopreserved Hu Hepatoyctes, 10 donor pool
Pack Size | Batch No. | Stock | COA |
AMY 5 million cells | 2310193 | 50 | HPCH10_2310193 |
HPCH20-50 - CryostaX, Single Freeze pooled cryopreserved human hepatoyctes, 20 donor pool
Pack Size | Batch No. | Stock | COA |
AMY 5.0 million cells | 2310301 | 10 | HPCH20-50_2310301 |
CYP001 - CYP1A2R Bactosomes Enzymes, 1 nmol CYP
Pack Size | Batch No. | Stock | COA |
1 nmol | C1A2R015D | 1 | NA |
CYP011 - CYP2A6R Bactosomes Enzymes, 1 nmol CYP
Pack Size | Batch No. | Stock | COA |
1 nmol | C2A6R008B | 1 | NA |
CYP-EZ028 - CYP2C19LR EasyCYP BACTOSOMES Enzymes , Low-Reductase , 0.5 nmol at 1 nmol/mL, 10 mg/mL protein
Pack Size | Batch No. | Stock | COA |
1 nmol | C2C19LR007/A | 1 | NA |
CYP017 - CYP2C8R Bactosomes Enzymes, 1 nmol CYP
Pack Size | Batch No. | Stock | COA |
1 nmol | C2C8R008 | 1 | NA |
CYP037 - CYP2C9HR + B5
Pack Size | Batch No. | Stock | COA |
1 nmol | C2C9BHR024 | 4 | NA |
CYP046 - CYP3A5R
Pack Size | Batch No. | Stock | COA |
1 nmol | C3A5R009 | 4 | NA |
Z6000 - Gottingen mini-pig liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 2310311 | 20 | Z6000 2310311 |
HMCSF-NODXR - Human Cerebrospinal Fluid 63 Individuals & Lot
Pack Size | Batch No. | Stock | COA |
200 ml | BRH1479741-BRH1479803 | 1 | NA |
CYP-EZ049 - Human CYP2C8 and human CYP-reductase coexpressed in Escherichia coli, supplemented with purified human cytochrome b5
Pack Size | Batch No. | Stock | COA |
0.5 nmol | C2C8BR005/A | 1 | NA |
H1000.H15B+ - Inducing cryopreserved male human hepatocytes
Pack Size | Batch No. | Stock | COA |
AMY 4.0 million cells | HC4-20 | 1 | NA |
H0610.L - Mixed Gender Human Liver Lysosomes
Pack Size | Batch No. | Stock | COA |
0.25ml | 2110249 | 2 | NA |
P2000.RH - Monkey Kidney Homogenate male cyno
Pack Size | Batch No. | Stock | COA |
1.0mL at 5 mg/mL | PR14026 | 3 | NA |
R1000.H15+ - Plateable cyropreserved male Sprague-Dawley rat hepatocytes
Pack Size | Batch No. | Stock | COA |
AMY 7.0 million cells | 1210242 | 1 | NA |
AMY 7.0 million cells | 1610409 | 4 | NA |
D1000 - Pooled Beagle dog liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml | 2110225 | 1 | D1000_2310325 |
0.5 ml | 2310325 | 400 | NA |
0.5 ml at 20 mg/ml (10 mg) | 2310325 | 102 | NA |
0.5 ml at 20 mg/ml (10 mg) | 2010046 | 2 | NA |
0.5 ml | 2010046 | 10 | NA |
D1000.S9 - Pooled Beagle dog liver S9 fraction, male
Pack Size | Batch No. | Stock | COA |
1.0 ml at 20 mg/ml (20 mg) | 2310053 | 20 | D1000.S9_2310053 |
M5000 - Pooled C57BL/6 mouse liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml | 2310302 | 100 | NA |
M1000.IS9(NP) - Pooled CD1 mouse intestinal S9 fraction, PMSF-free, male
Pack Size | Batch No. | Stock | COA |
1.0 ml | 1710100 | 1 | NA |
M1000 - Pooled CD1 mouse liver microsomes, male donor
Pack Size | Batch No. | Stock | COA |
0.5 ml | 2410002 | 64 | M1000_2410002 |
0.5 ml | 2210246 | 2 | NA |
0.5 ml at 20 mg/ml (10 mg) | 2410002 | 81 | NA |
0.5ml | 2410002 | 1 | NA |
0.5 ml | 2110330 | 1 | NA |
M1500 - Pooled CD1 mouse liver microsomes,female
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 2310308 | 5 | NA |
M1000.RS9 - Pooled CD1 Mouse Renal S9 fraction, male, 5 mg/mL
Pack Size | Batch No. | Stock | COA |
1.0ml | 1310040 | 3 | NA |
P2000.IC - Pooled Cynomolgus monkey intestinal cytosol,male
Pack Size | Batch No. | Stock | COA |
4 mg/ml - 1 ml | 1410046 | 3 | NA |
P2000.I - Pooled Cynomolgus monkey intestinal mcs, male
Pack Size | Batch No. | Stock | COA |
10 mg/mL - 150 ul | 1410047 | 3 | NA |
P2000.C - Pooled Cynomolgus monkey liver cytosol, male
Pack Size | Batch No. | Stock | COA |
1.0 ml | 1210333 | 2 | NA |
P2500 - Pooled Cynomolgus monkey liver microsomes, female
Pack Size | Batch No. | Stock | COA |
0.5 ml | 1210450 | 2 | NA |
0.5 ml | 1210450 | 2 | NA |
P2000 - Pooled Cynomolgus monkey liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5ml | 2210248 | 50 | NA |
0.5ml | 2110317 | 3 | NA |
P2500.S9 - Pooled Cynomolgus monkey liver S9 fraction, female
Pack Size | Batch No. | Stock | COA |
20 mg | 510057 | 10 | NA |
P2000.S9 - Pooled Cynomolgus monkey liver S9 fraction, male
Pack Size | Batch No. | Stock | COA |
1 ml | 1510192 | 1 | NA |
P2000.R - Pooled Cynomolgus monkey renal mcs, male
Pack Size | Batch No. | Stock | COA |
5 mg | 1110469 | 1 | NA |
S1000 - Pooled Golden Syrian hamster liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 2410062 | 5 | S1000_2410062 |
H0610.IS9 - Pooled human intestinal S9, mixed gender
Pack Size | Batch No. | Stock | COA |
1.0 ml at 4 mg/ml (4 mg) | 2310317 | 20 | NA |
H0610.C - Pooled human liver cytosol, mixed gender
Pack Size | Batch No. | Stock | COA |
1.0 ml at 10 mg/ml (10 mg) | 2310055 | 5 | H0610.C_2310055 |
H1000 - Pooled human liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml | 2410088 | 19 | H1000_2410088 |
H0610 - Pooled human liver microsomes, mixed gender, 20 mg/ml
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 2310056 | 189 | H0600_2310056 |
R1000 - Pooled IGS Sprague-Dawley rat liver microsomes, male
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 1910086 | 5 | R1000_2210274 |
0.5ml | 2210274 | 82 | NA |
0.5 ml | 1910100 | 1 | NA |
0.5 ml at 20 mg/ml (10 mg) | 2210274 | 179 | NA |
R1000.S9 - Pooled IGS Sprague-Dawley rat liver S9 fraction, male
Pack Size | Batch No. | Stock | COA |
1.0 ml at 20 mg/ml (20 mg) | 2210317 | 3 | R1000.S9_2210317 |
R6500 - Pooled Wistar Han rat liver microsomes, female, at 20 mg/ml (10 mg)
Pack Size | Batch No. | Stock | COA |
10 mg | 2110261 | 110 | NA |
CYP532 - S-mephenytoin
Pack Size | Batch No. | Stock | COA |
5 mg | 532001 | 3 | NA |
H2620 - XTreme 200 pool human liver microsomes, mixed gender
Pack Size | Batch No. | Stock | COA |
1.0 ml at 20 mg/ml (20 mg) | 2310132 | 23 | NA |
H2610 - XTreme 200 pool human liver microsomes, mixed gender
Pack Size | Batch No. | Stock | COA |
0.5 ml at 20 mg/ml (10 mg) | 1910096 | 32 | H2600_2310132 |
0.5 ml | 1910096 | 2 | NA |
0.5 ml at 20 mg/ml (10 mg) | 2310132 | 1000 | NA |
H2630.S9 - XTreme pooled human liver S9 fractions, mixed gender
Pack Size | Batch No. | Stock | COA |
5 ml | 910256 | 1 | NA |
The above stock represents ADME tissues and enzymes available with us in Mumbai. In case you are looking for plasma, sera or other CGT products, please view our CGT page here.
More About In Vitro Hepatocyte Models
Improving In Vivo Predictions from In Vitro Hepatocyte Models
Abstract: In both in vitro systems and in vivo, it is the unbound intracellular concentration (ICC) that is the driving force for processes that occur inside the hepatocyte. Achievement of an in vivo relevant ICC requires a polarized whole-cell system that integrates uptake into the hepatocyte, metabolism, and efflux (basolateral and canalicular) from the hepatocyte. Extensive protein binding can limit the uptake of many drugs, however for some drugs the estimation of intracellular concentration, and hepatic clearance cannot be correctly predicted based on the free (unbound) drug concentration. Additionally, studies have shown that transporters can be upregulated similar to metabolic proteins, resulting in increased uptake and/or efflux. Use of polarized whole-cell models and optimized culture conditions for in vitro systems may improve predictions of a drug’s in vivo properties and effects.
Flyers and Product Guides
- Flyers
- Product Guides
- White Papers
- Application Notes
Latest Blogs
Need More Information?
The Krishgen support team strives to provide swift responses and resolution to your queries. Get in touch for a technical question, product query or quote request.